Atlas Trials

Trial of Scheduled Versus Treatment Administration of Donor-Derived Viral Specific T-cells for Viral Infections After Stem Cell Transplant

Clinical trial NCT04230356 · RECRUITING

Trial details

NCT number
NCT04230356
Sponsor
Children's Hospital Medical Center, Cincinnati
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Allogeneic Stell Cell TransplantViral Infection
Start date
2021-01-27
Primary completion
2028-03-01
Enrollment
180

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.